For instance, associated with their tumor suppressor role, the hypermethylation of the SALL1 and SALL2 promoters were described in breast cancer and esophageal squamous cell carcinoma (ESCC) [54,55,92,93]. Here, SALL2 is linked to breast carcinoma.